79 related articles for article (PubMed ID: 22126760)
21. The relationship between the plasma concentration of irbesartan and the antihypertensive response is disclosed by an angiotensin II type 1 receptor polymorphism: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs. Atenolol (SILVHIA) Trial.
Kurland L; Hallberg P; Melhus H; Liljedahl U; Hashemi N; Syvänen AC; Lind L; Kahan T
Am J Hypertens; 2008 Jul; 21(7):836-9. PubMed ID: 18464745
[TBL] [Abstract][Full Text] [Related]
22. Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteinase activity.
Cipollone F; Fazia M; Iezzi A; Pini B; Cuccurullo C; Zucchelli M; de Cesare D; Ucchino S; Spigonardo F; De Luca M; Muraro R; Bei R; Bucci M; Cuccurullo F; Mezzetti A
Circulation; 2004 Mar; 109(12):1482-8. PubMed ID: 15037537
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of angiotension II type 1 receptor reduced human endothelial inflammation induced by low shear stress.
Chao Y; Zhu L; Qu X; Zhang J; Zhang J; Kong X; Gu Y; Pu J; Wu W; Ye P; Luo J; Yang H; Chen S
Exp Cell Res; 2017 Nov; 360(2):94-104. PubMed ID: 28843962
[TBL] [Abstract][Full Text] [Related]
24. Irbesartan inhibits human T-lymphocyte activation through downregulation of activator protein-1.
Cheng SM; Yang SP; Ho LJ; Tsao TP; Chang DM; Lai JH
Br J Pharmacol; 2004 Jul; 142(6):933-42. PubMed ID: 15210574
[TBL] [Abstract][Full Text] [Related]
25. Valsartan blocked alcohol-induced, Toll-like receptor 2 signaling-mediated inflammation in human vascular endothelial cells.
Wang Y; Li Y; Shen Q; Li X; Lu J; Li X; Yin D; Peng Y
Alcohol Clin Exp Res; 2014 Oct; 38(10):2529-40. PubMed ID: 25346502
[TBL] [Abstract][Full Text] [Related]
26. Irbesartan inhibits advanced glycation end product (AGE)-induced up-regulation of vascular cell adhesion molecule-1 (VCAM-1) mRNA levels in glomerular endothelial cells.
Matsui T; Nishino Y; Maeda S; Takeuchi M; Yamagishi S
Microvasc Res; 2011 May; 81(3):269-73. PubMed ID: 21236267
[TBL] [Abstract][Full Text] [Related]
27. Angiotensin II receptor blocker ameliorates stress-induced adipose tissue inflammation and insulin resistance.
Hayashi M; Takeshita K; Uchida Y; Yamamoto K; Kikuchi R; Nakayama T; Nomura E; Cheng XW; Matsushita T; Nakamura S; Murohara T
PLoS One; 2014; 9(12):e116163. PubMed ID: 25551221
[TBL] [Abstract][Full Text] [Related]
28. Cross-talk between inflammation and angiotensin II: studies based on direct transfection of cardiomyocytes with AT1R and AT2R cDNA.
Wang X; Khaidakov M; Ding Z; Mitra S; Lu J; Liu S; Mehta JL
Exp Biol Med (Maywood); 2012 Dec; 237(12):1394-401. PubMed ID: 23354398
[TBL] [Abstract][Full Text] [Related]
29. The angiotensin II receptor type 2 polymorphism influences haemodynamic function and circulating RAS mediators in normotensive humans.
Cherney DZ; Lai V; Miller JA; Scholey JW; Reich HN
Nephrol Dial Transplant; 2010 Dec; 25(12):4093-6. PubMed ID: 20844184
[TBL] [Abstract][Full Text] [Related]
30. Anti-inflammatory drug evaluation in ApoE-/- mice by ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging.
Sigovan M; Kaye E; Lancelot E; Corot C; Provost N; Majd Z; Breisse M; Canet-Soulas E
Invest Radiol; 2012 Sep; 47(9):546-52. PubMed ID: 22864378
[TBL] [Abstract][Full Text] [Related]
31. Role of angiotensin II receptor blockers in atherosclerotic plaque stability.
Cipollone F; Fazia ML; Mezzetti A
Expert Opin Pharmacother; 2006 Feb; 7(3):277-85. PubMed ID: 16448322
[TBL] [Abstract][Full Text] [Related]
32. Endothelial Protection, AT1 blockade and Cholesterol-Dependent Oxidative Stress: the EPAS trial.
Morawietz H; Erbs S; Holtz J; Schubert A; Krekler M; Goettsch W; Kuss O; Adams V; Lenk K; Mohr FW; Schuler G; Hambrecht R
Circulation; 2006 Jul; 114(1 Suppl):I296-301. PubMed ID: 16820589
[TBL] [Abstract][Full Text] [Related]
33. Up-regulation of PPARgamma in myocardial infarction.
Fliegner D; Westermann D; Riad A; Schubert C; Becher E; Fielitz J; Tschöpe C; Regitz-Zagrosek V
Eur J Heart Fail; 2008 Jan; 10(1):30-8. PubMed ID: 18162196
[TBL] [Abstract][Full Text] [Related]
34. Irbesartan administration therapeutically influences circulating endothelial progenitor cell and microparticle mobilization by involvement of pro-inflammatory cytokines.
Georgescu A; Alexandru N; Nemecz M; Titorencu I; Popov D
Eur J Pharmacol; 2013 Jul; 711(1-3):27-35. PubMed ID: 23639758
[TBL] [Abstract][Full Text] [Related]
35. Comparative expression profiling in primary and immortalized endothelial cells: changes in gene expression in response to hydroxy methylglutaryl-coenzyme A reductase inhibition.
Boerma M; Burton GR; Wang J; Fink LM; McGehee RE; Hauer-Jensen M
Blood Coagul Fibrinolysis; 2006 Apr; 17(3):173-80. PubMed ID: 16575254
[TBL] [Abstract][Full Text] [Related]
36. Effects of irbesartan on the growth and differentiation of adipocytes in obese zucker rats.
Di Filippo C; Lampa E; Tufariello E; Petronella P; Freda F; Capuano A; D'Amico M
Obes Res; 2005 Nov; 13(11):1909-14. PubMed ID: 16339122
[TBL] [Abstract][Full Text] [Related]
37. [Effects of irbesartan on nitric oxide system in the heart of diabetic rats].
Qian XX; Chen YM; Wu WK; Liu Y; Zhou B; Liu JL; Chen L
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Sep; 26(9):1359-62. PubMed ID: 16982456
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic effects of angiotensin II type 1 receptor blocker, irbesartan, on non-alcoholic steatohepatitis using FLS-ob/ob male mice.
Kato J; Koda M; Kishina M; Tokunaga S; Matono T; Sugihara T; Ueki M; Murawaki Y
Int J Mol Med; 2012 Jul; 30(1):107-13. PubMed ID: 22469867
[TBL] [Abstract][Full Text] [Related]
39. Irbesartan attenuates Ang II-induced BMP-2 expression in human umbilical vein endothelial cells.
Zhang M; Zhou SH; Zhao SP; Liu QM; Li XP; Shen XQ
Vasc Med; 2008 Aug; 13(3):239-45. PubMed ID: 18687761
[TBL] [Abstract][Full Text] [Related]
40. Angiotensin II mediates the high-glucose-induced endothelial-to-mesenchymal transition in human aortic endothelial cells.
Tang R; Li Q; Lv L; Dai H; Zheng M; Ma K; Liu B
Cardiovasc Diabetol; 2010 Jul; 9():31. PubMed ID: 20663195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
